Modified Nucleosides
2',3',5'-Tri-O-(tert-butyldimethylsilyl)-4'-C-(hydroxymethyl)uridine
Quick view. Uridine derivative bearing a free 4'-C-hydroxymethyl substituent and tert-butyldimethylsilyl protection at the 2', 3', and 5' oxygens. CAS 232588-97-5. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
2',3',5'-Tri-O-(tert-butyldimethylsilyl)-4'-C-(hydroxymethyl)uridine is classified as modified nucleosides (Formula C28H56N2O7Si3; molecular weight 617.00 g/mol).
2',3',5'-Tri-O-(tert-butyldimethylsilyl)-4'-C-(hydroxymethyl)uridine is associated with cytosine-containing building blocks or substrates for C-position incorporation and analytical comparison.
For 2',3',5'-Tri-O-(tert-butyldimethylsilyl)-4'-C-(hydroxymethyl)uridine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Useful catalog search terms
- 232588-97-5
Physicochemical data
| PubChem CID | 10531874 |
|---|---|
| Nucleoside scaffold | Uridine |
| Substitution pattern | 4'-C-(hydroxymethyl) |
| Protecting groups | 2',3',5'-tri-O-tert-butyldimethylsilyl |
| IUPAC name | 1-[(2R,3R,4S,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
| InChIKey | MFONQURJGXWANN-JTNFPWQOSA-N |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 2',3',5'-Tri-O-(tert-butyldimethylsilyl)-4'-C-(hydroxymethyl)uridine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0404 and CAS 232588-97-5, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.